Bulletin
Investor Alert

Neoleukin Therapeutics Inc.

NAS: NLTX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206057284/composite

$

11.61

Change

0.00 0.00%

Volume

Volume 7,624

Sep 25, 2020, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206057284/composite

Previous close

$ 11.23

$ 11.61

Change

+0.38 +3.38%

Day low

Day high

$11.12

$11.79

Open
Open: 11.15

52 week low

52 week high

$2.53

$18.13

Open

Market cap

$484.71M

Average volume

240,649

P/E ratio

N/A

Rev. per Employee

$3.13M

EPS

-2.86

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nltx

MarketWatch News on NLTX

  1. Neoleukin Therapeutics started at buy with $21 stock price target at Mizuho

    6:43 a.m. June 18, 2020

    - Tomi Kilgore

  2. Stocks breaking out include Neoleukin Therapeutics and XPEL

    3:22 p.m. Jan. 23, 2020

    - Harry Boxer

  3. Charting the Market

    8:55 a.m. July 5, 2018

    - Barron's Online

  4. Aquinox to review pipeline and provide guidance later this year

    6:51 a.m. June 27, 2018

    - Ciara Linnane

  5. Aquinox Pharma says trial of cystitis treatment failed to meet main goal

    6:50 a.m. June 27, 2018

    - Ciara Linnane

  6. Aquinox Pharma shares slide 12% premarket

    6:50 a.m. June 27, 2018

    - Ciara Linnane

  7. Aquinox says results support halting all further development

    6:51 a.m. June 27, 2018

    - Ciara Linnane

  8. Baker Bros. Adds to Its Stake in Aquinox Pharmaceuticals

    3:18 a.m. Jan. 14, 2017

    - Barron's Online

  9. The Next Big Moves in Health-Care Stocks

    6:14 a.m. Oct. 25, 2016

    - Barron's Online

  10. Two Cancer Biotechs See Bullish Insider Buying

    2:24 p.m. Sept. 27, 2016

    - Barron's Online

  11. 13Ds Filed With the Securities and Exchange Commission

    8:41 p.m. Feb. 5, 2016

    - Barron's Online

  12. 13D Filings

    12:44 a.m. Sept. 19, 2015

    - Barron's Online

  13. China’s surprise can keep the market’s Fed-fueled party going

    8:21 a.m. Aug. 11, 2015

    - Victor Reklaitis

  14. Aquinox Pharmaceuticals shares up 48.8% in premarket trade

    7:58 a.m. Aug. 11, 2015

    - Ciara Linnane

  15. Aquinox stock rockets 2000%, Twitter goes nuts

    4:24 p.m. Aug. 10, 2015

    - Jennifer Booton

  16. Aquinox Pharmaceuticals stock skyrockets 450%

    3:22 p.m. Aug. 7, 2015

    - Jennifer Booton

  17. Almost half of venture-backed IPOs this year are losers

    6:00 a.m. Oct. 3, 2014

    - Philip van Doorn

Analyst Ratings

/news/nonmarketwatch/company/us/nltx

Other News on NLTX

  1. Neoleukin Therapeutics (NLTX) Investor Presentation - Slideshow

    3:36 p.m. Aug. 16, 2020

    - Seeking Alpha

  2. 10-Q: NEOLEUKIN THERAPEUTICS, INC.

    4:08 p.m. Aug. 12, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  3. Neoleukin drops 15% after pricing stock offering

    9:37 a.m. July 2, 2020

    - Seeking Alpha

  4. Stocks To Watch: Nike, Apple, Ford And Stressed Banks

    8:39 a.m. June 20, 2020

    - Seeking Alpha

  5. 10-Q: NEOLEUKIN THERAPEUTICS, INC.

    4:29 p.m. May 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. 10-K: NEOLEUKIN THERAPEUTICS, INC.

    4:09 p.m. March 12, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  7. Stocks To Watch: Time For Coronavirus Offense Or Defense?

    9:26 a.m. Feb. 29, 2020

    - Seeking Alpha

  8. Citigroup sees 36% upside in Amarin in premarket analyst action

    9:49 a.m. Feb. 18, 2020

    - Seeking Alpha

  9. Neoleukin Therapeutics (NLTX) Investor Presentation - Slideshow

    3:10 p.m. Jan. 15, 2020

    - Seeking Alpha

  10. Weekly CEO Buys Highlight

    2:44 p.m. Dec. 30, 2019

    - GuruFocus.com

  11. Neoleukin prices equity offering at $8.40

    7:05 a.m. Dec. 18, 2019

    - Seeking Alpha

  12. Loading more headlines...
/news/pressrelease/company/us/nltx

Press Releases on NLTX

  1. Neoleukin Therapeutics Announces Proposed Public Offering

    4:05 p.m. July 1, 2020

    - GlobeNewswire

  2. Neoleukin Therapeutics Announces Proposed Public Offering

    4:01 p.m. July 1, 2020

    - GlobeNewswire

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.